About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [684 citations: 201–300 of 646 articles]

Articles published in Prostate Cancer have been cited 684 times. The following is a list of the 646 articles that have cited the articles published in Prostate Cancer.

  • Luciane Rostirola Cavazzola, Gustavo Franco Carvalhal, Candida Deves, Daiana Renck, Ricardo Almeida, and Diogenes Santiago Santos, “Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and ,” Oncology Letters, vol. 9, no. 6, pp. 2886–2894, 2015. View at Publisher · View at Google Scholar
  • Marina Gobbe Moschetta, Larissa Bazela Maschio, Bruna Victorasso Jardim-Perassi, Gabriela Bottaro Gelaleti, Juliana Ramos Lopes, Camila Leonel, Naiane Do Nascimento Goncalves, Livia Carvalho Ferreira, Gustavo Rodrigues Martins, Thaiz Perraz Borin, and Debora Aparecida Pires De Campos Zuccari, “Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1 alpha in canine malignant mammary tumors,” Oncology Reports, vol. 33, no. 5, pp. 2345–2353, 2015. View at Publisher · View at Google Scholar
  • Swati Dhar, Avinash Kumar, Agnes M. Rimando, Xu Zhang, and Anait S. Levenson, “Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer,” Oncotarget, vol. 6, no. 29, pp. 27214–27226, 2015. View at Publisher · View at Google Scholar
  • Burkhard Helpap, Daniel Ringli, Jens Tonhauser, Immanuel Poser, Jürgen Breul, Heidrun Gevensleben, and Hans-Helge Seifert, “The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer,” Pathology & Oncology Research, 2015. View at Publisher · View at Google Scholar
  • Hemant K. Roy, Charles B. Brendler, Hariharan Subramanian, Di Zhang, Charles Maneval, John Chandler, Leah Bowen, Karen L. Kaul, Brian T. Helfand, Chi-Hsiung Wang, Margo Quinn, Jacqueline Petkewicz, Michael Paterakos, and Vadim Backman, “Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study,” Plos One, vol. 10, no. 2, 2015. View at Publisher · View at Google Scholar
  • Andrea Dueregger, Bernd Schoepf, Theresa Eder, Julia Hoefer, Erich Gnaiger, Astrid Aufinger, Lukas Kenner, Bernhard Perktold, Reinhold Ramoner, Helmut Klocker, and Iris E. Eder, “Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate,” Plos One, vol. 10, no. 8, 2015. View at Publisher · View at Google Scholar
  • Maria Nilsson, Christina Hagglof, Peter Hammarsten, Elin Thysell, Par Stattin, Lars Egevad, Torvald Granfors, Emma Jernberg, Pernilla Wikstrom, Sofia Halin Bergstrom, and Anders Bergh, “High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting,” Plos One, vol. 10, no. 10, 2015. View at Publisher · View at Google Scholar
  • Hanibal Hani Adamo, Kerstin Stromvall, Maria Nilsson, Sofia Halin Bergstrom, and Anders Bergh, “Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness,” Plos One, vol. 10, no. 11, 2015. View at Publisher · View at Google Scholar
  • Anna C. Jones, Kresta S. Antillon, Shannon M. Jenkins, Sara N. Janos, Heidi N. Overton, Dor S. Shoshan, Edgar G. Fischer, Kristina A. Trujillo, and Marco Bisoffi, “Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumo,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Brittany L. Mihelich, Joseph C. Maranville, Rosalie Nolley, Donna M. Peehl, and Larisa Nonn, “Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort,” Plos One, vol. 10, no. 4, 2015. View at Publisher · View at Google Scholar
  • Jennifer S. Myers, Ariana K. von Lersner, Charles J. Robbins, and Qing-Xiang Amy Sang, “Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer,” Plos One, vol. 10, no. 12, 2015. View at Publisher · View at Google Scholar
  • Cesaltina Lorenzoni, Alba Vilajeliu, Carla Carrilho, Mamudo R. Ismail, Paola Castillo, Orvalho Augusto, Alberto L. Garcia-Basteiro, Mohsin Sidat, Silvia de Sanjose, Clara Menendez, and Jaume Ordi, “Trends in Cancer Incidence in Maputo, Mozambique, 1991-2008,” Plos One, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • Chang Xu, Fang-Fang Han, Xian-Tao Zeng, Tong-Zu Liu, Shen Li, and Zheng-Yan Gao, “Fat Intake Is Not Linked to Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis,” Plos One, vol. 10, no. 7, 2015. View at Publisher · View at Google Scholar
  • Johannes H. Matse, Janice Yoshizawa, Xiaoyan Wang, David Elashoff, Jan G. M. Bolscher, Enno C. I. Veerman, C. Rene Leemans, Michiel D. Pegtel, David T. W. Wong, and Elisabeth Bloemena, “Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms,” Plos One, vol. 10, no. 11, 2015. View at Publisher · View at Google Scholar
  • Sheen Cherian, Jeffrey A. Kittel, Chandana A. Reddy, Matthew D. Kolar, James Ulchaker, Kenneth Angermeier, Kevin L. Stephans, Rahul D. Tendulkar, Eric Klein, and Jay P. Ciezki, “Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis,” Practical Radiation Oncology, 2015. View at Publisher · View at Google Scholar
  • Shozo Honda, Phillipe Loher, Megumi Shigematsu, Juan P. Palazzo, Ryusuke Suzuki, Issei Imoto, Isidore Rigoutsos, and Yohei Kirino, “Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers,” Proceedings of the National Academy of Sciences, vol. 112, no. 29, pp. E3816–E3825, 2015. View at Publisher · View at Google Scholar
  • L. Salomon, F. Rozet, and M. Soulié, “La chirurgie du cancer de la prostate : principes techniques et complications péri-opératoires,” Progrès en Urologie, vol. 25, no. 15, pp. 966–998, 2015. View at Publisher · View at Google Scholar
  • Pedro Fernandez, Muneeb Salie, Danielle du Toit, and Andre van der Merwe, “Analysis of Prostate Cancer Susceptibility Variants in South African Men: Replicating Associations on Chromosomes 8q24 and 10q11,” Prostate Cancer, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Maria José Ribal, Juan Ignacio Martínez-Salamanca, and Camilo García Freire, “Current Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain,” Prostate Cancer, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • R van Velthoven, F Aoun, Q Marcelis, S Albisinni, M Zanaty, M Lemort, A Peltier, and K Limani, “A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer,” Prostate Cancer and Prostatic Disease, 2015. View at Publisher · View at Google Scholar
  • L C Macleod, L J Chery, E Y C Hu, S B Zeliadt, S K Holt, D W Lin, M P Porter, J L Gore, and J L Wright, “Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort,” Prostate Cancer and Prostatic Disease, 2015. View at Publisher · View at Google Scholar
  • Romy E. D. Lamers, Maarten Cuypers, Olga Husson, Marieke de Vries, Paul J. M. Kil, J. L. H. Ruud Bosch, and Lonneke V. van de Poll-Franse, “Patients are dissatisfied with information provision: perceived information provision and quality of life in prostate cancer patients,” Psycho-Oncology, 2015. View at Publisher · View at Google Scholar
  • Tracey Ledoux, Heather Adamus-Leach, Daniel P. O'Connor, Scherezade Mama, and Rebecca E. Lee, “The association of binge eating and neighbourhood fast-food restaurant availability on diet and weight status,” Public Health Nutrition, vol. 18, no. 2, pp. 352–360, 2015. View at Publisher · View at Google Scholar
  • Eamonn O’Leary, Frances J. Drummond, Anna Gavin, Heather Kinnear, and Linda Sharp, “Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate’s egg,” Quality of Life Research, 2015. View at Publisher · View at Google Scholar
  • Colin Rae, Uwe Haberkorn, John W. Babich, and Robert J. Mairs, “Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy,” Radiation Research, vol. 184, no. 5, pp. 482–493, 2015. View at Publisher · View at Google Scholar
  • Adem Karaman, Irmak Durur-Subasi, Fatih Alper, Omer Araz, Mahmut Subasi, Elif Demirci, Mevlut Albayrak, Gokhan Polat, Metin Akgun, and Nevzat Karabulut, “Correlation of diffusion MRI with the Ki-67 index in non-small cell lung cancer,” Radiology And Oncology, vol. 49, no. 3, pp. 250–255, 2015. View at Publisher · View at Google Scholar
  • James W. Denham, Allison Steigler, David Joseph, David S. Lamb, Nigel A. Spry, Gillian Duchesne, Chris Atkinson, John Matthews, Sandra Turner, Lizbeth Kenny, Keen-Hun Tai, Nirdosh Kumar Gogna, Suki Gill, Hendrick Tan, Rachel Kearvell, Judy Murray, Martin Ebert, Annette Haworth, Angel Kennedy, Brett Delahunt, Christopher Oldmeadow, Elizabeth G. Holliday, and John Attia, “Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial,” Radiotherapy And Oncology, vol. 115, no. 3, pp. 301–307, 2015. View at Publisher · View at Google Scholar
  • Joseph R. Evans, Shuang Zhao, Stephanie Daignault, Martin G. Sanda, Jeff Michalski, Howard M. Sandler, Deborah A. Kuban, Jay Ciezki, Irving D. Kaplan, Anthony L. Zietman, Larry Hembroff, Felix Y. Feng, Simeng Suy, Ted A. Skolarus, Patrick W. McLaughlin, John T. Wei, Rodney L. Dunn, Steven E. Finkelstein, Constantine A. Mantz, Sean P. Collins, and Daniel A. Hamstra, “Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy,” Radiotherapy and Oncology, 2015. View at Publisher · View at Google Scholar
  • Abdulmaged M. Traish, and Michael Zitzmann, “The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease,” Reviews in Endocrine and Metabolic Disorders, 2015. View at Publisher · View at Google Scholar
  • S. Vidal-Sicart, and R.A. Valdés Olmos, “Sentinel node approach in prostate cancer,” Revista Española de Medicina Nuclear e Imagen Molecular, 2015. View at Publisher · View at Google Scholar
  • J.R. Chícharo de Freitas, G.H. KleinJan, H.G. van der Poel, N.S. van den Berg, E. Vegt, M.P. Stokkel, and R.A. Valdés Olmos, “Utility of SPECT/CT scan for anatomical localization of pararectal and presacral sentinel nodes in prostate cancer,” Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), vol. 34, no. 1, pp. 19–23, 2015. View at Publisher · View at Google Scholar
  • S. Vidal-Sicart, and R.A. Valdés Olmos, “Sentinel node approach in prostate cancer,” Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), vol. 34, no. 6, pp. 358–371, 2015. View at Publisher · View at Google Scholar
  • O. E. Mustafina, I. A. Tuktarova, D. D. Karimov, R. Sh. Somova, and T. R. Nasibullin, “CYP2D6, CYP3A5, and CYP3A4 gene polymorphisms in Russian, Tatar, and Bashkir populations,” Russian Journal of Genetics, vol. 51, no. 1, pp. 98–107, 2015. View at Publisher · View at Google Scholar
  • D. C. Stefan, D. K. Stones, R. D. Wainwright, M. Kruger, A. Davidson, J. Poole, G. P. Hadley, D. Forman, M. Colombet, and E. Steliarova-Foucher, “Childhood cancer incidence in South Africa, 1987-2007,” Samj South African Medical Journal, vol. 105, no. 11, pp. 939–947, 2015. View at Publisher · View at Google Scholar
  • E. Singh, J. M. Underwood, C. Nattey, C. Babb, M. Sengayi, and P. Kellett, “South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates,” Samj South African Medical Journal, vol. 105, no. 2, pp. 107–109, 2015. View at Publisher · View at Google Scholar
  • Marie Østby-Deglum, Bjørn Brennhovd, Karol Axcrona, Sophie D. Fosså, and Alv A. Dahl, “A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy,” Scandinavian Journal of Urology, vol. 49, no. 6, pp. 433–439, 2015. View at Publisher · View at Google Scholar
  • Frederik Birkebæk Thomsen, Kasper Drimer Berg, Peter Iversen, and Klaus Brasso, “Poor association between the progression criteria in active surveillance and subsequent histopathological findings following radical prostatectomy,” Scandinavian Journal of Urology, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Carrie D. House, Bi-Dar Wang, Kristin Ceniccola, Russell Williams, May Simaan, Jacqueline Olender, Vyomesh Patel, Daniel T. Baptista-Hon, Christina M. Annunziata, J. Silvio Gutkind, Tim G. Hales, and Norman H. Lee, “Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Cao De Hong, Liu Liang Ren, Wei Qiang, Wang Jia, Hu Ying Chun, Yang Lu, Liu Zheng Hua, Li Heng Ping, Yan Shi Bing, and Li Yun Xiang, “Comparison of efficacy and safety of conventional laparoscopic radical prostatectomy by the transperitoneal versus extraperitoneal procedure,” Scientific Reports, vol. 5, pp. 14442, 2015. View at Publisher · View at Google Scholar
  • Jiajia Hu, Hu Lei, Xiaochun Fei, Sheng Liang, Hanzhang Xu, Dongjun Qin, Yue Wang, Yingli Wu, and Biao Li, “NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells,” Scientific Reports, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Ruhani Singh, Marck Norret, Michael J. House, Yuriy Galabura, Michael Bradshaw, Diwei Ho, Robert C. Woodward, Timothy G. St. Pierre, Igor Luzinov, Nicole M. Smith, Lee Yong Lim, and Killugudi Swaminathan Iyer, “Dose-Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin-Coated PGMA Nanoparticles,” Small, 2015. View at Publisher · View at Google Scholar
  • Amy L. Strong, Matthew E. Burow, Jeffrey M. Gimble, and Bruce A. Bunnell, “Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells,” Stem Cells, vol. 33, no. 2, pp. 318–326, 2015. View at Publisher · View at Google Scholar
  • William Tabayoyong, and Robert Abouassaly, “Prostate Cancer Screening and the Associated Controversy,” Surgical Clinics of North America, 2015. View at Publisher · View at Google Scholar
  • Hayato Urushima, Yukiko Inomata-Kurashiki, Kazuo Nishimura, Ryoko Sumi, Iichiro Shimomura, Norio Nonomura, Toshinori Ito, and Kazuhisa Maeda, “The effects of androgen deprivation therapy with weight management on serum aP2 and adiponectin levels in prostate cancer patients,” The Aging Male, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Mostafa Mohamed Mostafa Elian, Enas Ahmed Abdel Gawad, and Tarek K.H. Fathelbab, “Value of functional MRI in evaluation of patients with suspected prostate cancer,” The Egyptian Journal of Radiology and Nuclear Medicine, 2015. View at Publisher · View at Google Scholar
  • David A. Jolliffe, Robert T. Walton, Christopher J. Griffiths, and Adrian R. Martineau, “Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies,” The Journal of Steroid Biochemistry and Molecular Biology, 2015. View at Publisher · View at Google Scholar
  • Javier C. Angulo, Guillermo Andrés, Nadia Ashour, Manuel Sánchez-Chapado, Jose I. López, and Santiago Ropero, “Development of Castration Resistant Prostate Cancer Can Be Predicted by a DNA Hypermethylation Profile,” The Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Arachk de Gorski, Morgan Rouprêt, Benoit Peyronnet, Chloé Le Cossec, Benjamin Granger, Eva Comperat, Olivier Cussenot, Raphaële Renard-Penna, and Pierre Mozer, “Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinical significant prostate cancer in enlarged compared to smaller prostates,” The Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Alvarez, Carmen Gonzalez San Segundo, Maria Angeles Cabeza Rodríguez, Victor Macias, Agustí Pedro Olive, Francesc Casas, Ana Boladeras, Carmen Martín de Vidales, Maria Luisa Vazquez de la Torre, Salvador Villà, Aitor Perez de la Haza, and Felipe A Calvo, “High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial,” The Lancet Oncology, 2015. View at Publisher · View at Google Scholar
  • Henrique J. Cardoso, Cátia V. Vaz, Sara Correia, Marília I. Figueira, Ricardo Marques, Cláudio J. Maia, and Sílvia Socorro, “Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Roque Diaz, Paul A. Nguewa, Miriam Redrado, Irene Manrique, and Alfonso Calvo, “Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • C. J. Paller, Y. M. Kanaan, D. A. Beyene, T. J. Naab, R. L. Copeland, H. L. Tsai, N. F. Kanarek, and T. S. Hudson, “Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • John P. McCrow, Desiree C. Petersen, Melanie Louw, Eva K. F. Chan, Katherine Harmeyer, Stefano Vecchiarelli, Ruth J. Lyons, M. S. Riana Bornman, and Vanessa M. Hayes, “Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Kenneth C. Valkenburg, Galen Hostetter, and Bart O. Williams, “Concurrent Hepsin overexpression and adenomatous polyposis coli deletion causes invasive prostate carcinoma in mice,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Bita NickKholgh, Xiaolan Fang, Shira M. Winters, Anvi Raina, Komal S. Pandya, Kenneth Gyabaah, Nora Fino, and K.C. Balaji, “Cell line modeling to study biomarker panel in prostate cancer,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Xinyu Yang, M. Francesca Monn, Libo Liu, Yuli Liu, Jinwei Su, Tianjing Lyu, Yanqing Gong, Lisha Wang, Darrell D. Davidson, and Liang Cheng, “Incidental prostate cancer in Asian men: High prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy,” The Prostate, 2015. View at Publisher · View at Google Scholar
  • Chao-hui Hao, Qian-he Han, Zhong-jie Shan, Jian-ting Hu, Nan Zhang, and Xue-pei Zhang, “Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody,” Theoretical Biology and Medical Modelling, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Satoko Sato, Mika Watanabe, Shinji Taniuchi, Atsuko Kasajima, Koji Mitsuzuka, Yasuhiro Nakamura, Fumiyoshi Fujishima, Yoichi Arai, and Hironobu Sasano, “Precise Preoperative Localization of Prostate Cancer Employing 12-Core Needle Biopsy with a Tissue-Marking Method for Effective Surgical Strategy,” Tohoku Journal Of Experimental Medicine, vol. 236, no. 1, pp. 55–61, 2015. View at Publisher · View at Google Scholar
  • Rachel M. Jones, Claire Morgan, and Gianfilippo Bertelli, “Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer,” Tumor Biology, vol. 36, no. 6, pp. 4861–4869, 2015. View at Publisher · View at Google Scholar
  • Yanmei Chen, Chengzhao Lin, Yang Liu, and Yan Jiang, “HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Seyed Hamid Aghaee-Bakhtiari, Ehsan Arefian, Mahmood Naderi, Farshid Noorbakhsh, Vahideh Nodouzi, Mojgan Asgari, Pezhman Fard-Esfahani, Reza Mahdian, and Masoud Soleimani, “MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • D. Baumunk, and M. Schostak, “Treatment of localized prostate cancer with high-intensity focused ultrasound,” Urologe, vol. 54, no. 2, pp. 183–190, 2015. View at Publisher · View at Google Scholar
  • Qi Shi, Yang Gao, Shan Xu, Chong Du, Feng Li, Xiao-Shuang Tang, Jing Jia, Xinyang Wang, Luke Chang, Dalin He, and Peng Guo, “Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7,” Urologic Oncology: Seminars and Original Investigations, 2015. View at Publisher · View at Google Scholar
  • Sally M. Hunter, Simone M. Rowley, David Clouston, Jason Li, Richard Lupat, Nishanth Krishnananthan, Gail Risbridger, Renea Taylor, Damien Bolton, Ian G. Campbell, and Heather Thorne, “Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2015. View at Publisher · View at Google Scholar
  • Abdullah M. Alenizi, Marc Bienz, Emad Rajih, Anwar Alesawi, Naif Al-Hathal, Serge Benayoun, Thierry Lebeau, Kevin C. Zorn, and Assaad El-Hakim, “Uroflow Stop Test and Potency Recovery: A Surrogate for Pelvic Floor Integrity Post Robotic-Assisted Radical Prostatectomy?,” Urology, 2015. View at Publisher · View at Google Scholar
  • Wesley W. Ludwig, Michael A. Gorin, Mark W. Ball, Edward M. Schaeffer, Misop Han, and Mohamad E. Allaf, “Instrument Life for Robot-Assisted Laparoscopic Radical Prostatectomy and Partial Nephrectomy: Are Ten Lives for Most Instruments Justified?,” Urology, 2015. View at Publisher · View at Google Scholar
  • Neil Mendhiratta, Ted Lee, Vinay Prabhu, Elton Llukani, and Herbert Lepor, “10-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era,” Urology, 2015. View at Publisher · View at Google Scholar
  • Stéphanie Tran, Romain Boissier, Jeanne Perrin, Gilles Karsenty, and Eric Lechevallier, “Review of the Different Treatments and Management for Prostate Cancer and Fertility,” Urology, vol. 86, no. 5, pp. 936–941, 2015. View at Publisher · View at Google Scholar
  • Robert H. Blackwell, Alexander M. Kandabarow, Gopal N. Gupta, Matthew M. Harkenrider, Marcus L. Quek, and Robert C. Flanigan, “Long-Term Incidence of Hematuria, Urethral Stricture and Bladder Cancer after Radiation Therapy for Prostate Cancer,” Urology Practice, 2015. View at Publisher · View at Google Scholar
  • J. K. Simmons, B. E. Hildreth, W. Supsavhad, S. M. Elshafae, B. B. Hassan, W. P. Dirksen, R. E. Toribio, and T. J. Rosol, “Animal Models of Bone Metastasis,” Veterinary Pathology, vol. 52, no. 5, pp. 827–841, 2015. View at Publisher · View at Google Scholar
  • Xiao Shen, and Wei-Qin Li, “High-mobility group box 1 protein and its role in severe acute pancreatitis,” World Journal Of Gastroenterology, vol. 21, no. 5, pp. 1424–1435, 2015. View at Publisher · View at Google Scholar
  • Jonas Busch, Mark L. Gonzalgo, Natalia Leva, Michelle Ferrari, Hannes Cash, Carsten Kempkensteffen, Stefan Hinz, Kurt Miller, and Ahmed Magheli, “Matched comparison of robotaEuroassisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients,” World Journal Of Urology, vol. 33, no. 3, pp. 397–402, 2015. View at Publisher · View at Google Scholar
  • Taimur T. Shah, Veeru Kasivisvanathan, Charles Jameson, Alex Freeman, Mark Emberton, and Hashim U. Ahmed, “Histological outcomes after focal high-intensity focused ultrasound and cryotherapy,” World Journal Of Urology, vol. 33, no. 7, pp. 955–964, 2015. View at Publisher · View at Google Scholar
  • Alessandro Conti, Matteo Santoni, Luciano Burattini, Marina Scarpelli, Roberta Mazzucchelli, Andrea B. Galosi, Liang Cheng, Antonio Lopez-Beltran, Alberto Briganti, Francesco Montorsi, and Rodolfo Montironi, “Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients,” World Journal of Urology, 2015. View at Publisher · View at Google Scholar
  • G. A. Gomez, P. F. Gutierrez, R. Lopez-Cubillana, and P. Lopez, “Is minimally invasive transanal surgery an alternative for rectal-urinary fistula correction?,” Actas Urologicas Espanolas, vol. 38, no. 4, pp. 276–277, 2014. View at Publisher · View at Google Scholar
  • Rose G. Radin, Shiriki K. Kumanyika, Edward A. Ruiz-Narvaez, Julie R. Palmer, and Lynn Rosenberg, “Prospective study of dietary fat and risk of uterine leiomyomata,” American Journal of Clinical Nutrition, vol. 99, no. 5, pp. 1105–1116, 2014. View at Publisher · View at Google Scholar
  • Youngyo Kim, and Youjin Je, “Dietary Fiber Intake and Total Mortality: A Meta-Analysis of Prospective Cohort Studies,” American Journal of Epidemiology, vol. 180, no. 6, pp. 565–573, 2014. View at Publisher · View at Google Scholar
  • Nathan A. Berger, “Obesity and cancer pathogenesis,” Annals of the New York Academy of Sciences, vol. 1311, no. 1, pp. 57–76, 2014. View at Publisher · View at Google Scholar
  • Edoardo Francini, Anna Ida Fiaschi, Roberto Petrioli, Filippo Francini, Vincenzo Bianco, Armando Perrella, Giovanni Paganini, Letizia Laera, and Giandomenico Roviello, “Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 472–477, 2014. View at Publisher · View at Google Scholar
  • Helen Blanchard, Khuchtumur Bum-Erdene, and Matthew W. Hugo, “Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics,” Australian Journal of Chemistry, vol. 67, no. 12, pp. 1763, 2014. View at Publisher · View at Google Scholar
  • Er-Jiang Lin, Xian Zhang, Da-Ya Wang, Shi-Zhe Hong, and Lei-Yu Li, “Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases-2/-9 via ROS/ERK1/2 pathways,” Bangladesh Journal of Pharmacology, vol. 9, no. 3, pp. 419–427, 2014. View at Publisher · View at Google Scholar
  • Apollo D. Kacsinta, Cynthia S. Rubenstein, Isis C. Sroka, Sangita Pawar, Jaime M. Gard, Raymond B. Nagle, and Anne E. Cress, “Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Katsura Kakoki, Haruka Kamiyama, Mai Izumida, Yuka Yashima, Hideki Hayashi, Naoki Yamamoto, Toshifumi Matsuyama, Tsukasa Igawa, Hideki Sakai, and Yoshinao Kubo, “Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Siegfried Wagner, Anaclet Ngezahayo, Hugo Murua Escobar, and Ingo Nolte, “ Role of miRNA Let-7 and Its Major Targets in Prostate Cancer ,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Adam M. Hirst, Fiona M. Frame, Norman J. Maitland, and Deborah O’Connell, “Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?,” BioMed Research International, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Jan Tykvart, Jiří Schimer, Jitka Bařinková, Petr Pachl, Lenka Poštová-Slavětínská, Pavel Majer, Jan Konvalinka, and Pavel Šácha, “Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Andrea R. Spence, Marie-Claude Rousseau, Pierre I. Karakiewicz, and Marie-Élise Parent, “Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada,” BJU International, 2014. View at Publisher · View at Google Scholar
  • Gillian M. Duchesne, and Henry H. Woo, “The ‘Timing of Androgen-Deprivation therapy in incurable prostate cancer’ protocol (TOAD) - where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial,” BJU International, vol. 114, pp. 9–12, 2014. View at Publisher · View at Google Scholar
  • Haidar Abdul-Muhsin, Camilo Giedelman, Srinivas Samavedi, Oscar Schatloff, Rafael Coelho, Bernardo Rocco, Kenneth Palmer, George Ebra, and Vipul Patel, “Perioperative and early oncological outcomes after robot-assisted radical prostatectomy (RARP) in morbidly obese patients: a propensity score-matched ,” Bju International, vol. 113, no. 1, pp. 84–91, 2014. View at Publisher · View at Google Scholar
  • Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh, and Andrew J. Armstrong, “Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC),” BJU International, 2014. View at Publisher · View at Google Scholar
  • Elina Korpela, Darren Yohan, Lee C. L. Chin, Anthony Kim, Xiaoyong Huang, Shachar Sade, Paul Van Slyke, Daniel J. Dumont, and Stanley K. Liu, “Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Ying Zhang, Thomas Perez, Beth Blondin, Jing Du, Ping Liu, Diana Escarzaga, John S. Coon, Larry E. Morrison, and Katerina Pestova, “Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Morten Beck Rye, Helena Bertilsson, Finn Drablos, Anders Angelsen, Tone F. Bathen, and May-Britt Tessem, “Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer,” Bmc Medical Genomics, vol. 7, 2014. View at Publisher · View at Google Scholar
  • Kelvin A. Moses, Ling Y. Chen, Daniel D. Sjoberg, Melanie Bernstein, and Karim A. Touijer, “Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy,” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Sigve Andersen, Elin Richardsen, Yngve Nordby, Nora Ness, Oystein Storkersen, Khalid Al-Shibli, Tom Donnem, Helena Bertilsson, Lill-Tove Busund, Anders Angelsen, and Roy M. Bremnes, “Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time,” Bmc Urology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Juanita Crook, “Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Andrew S. Hyatt, Emily H. Neubauer-Sugar, Desmond A. O'Farrell, Michael P. O'Leary, Graeme S. Steele, Thomas R. Niedermayr, Clair J. Beard, Neil E. Martin, Peter F. Orio, Anthony V. D'Amico, Phillip M. Devlin, and Paul L. Nguyen, “Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • A Paziewska, M Dabrowska, K Goryca, A Antoniewicz, J Dobruch, M Mikula, D Jarosz, L Zapala, A Borowka, and J Ostrowski, “DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • M Shipitsin, C Small, S Choudhury, E Giladi, S Friedlander, J Nardone, S Hussain, A D Hurley, C Ernst, Y E Huang, H Chang, T P Nifong, D L Rimm, J Dunyak, M Loda, D M Berman, and P Blume-Jensen, “Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Elizabeth J. Davis, Jennifer L. Beebe-Dimmer, Cecilia L. Yee, and Kathleen A. Cooney, “Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study,” Cancer, 2014. View at Publisher · View at Google Scholar